Seattle Genetics Inc (NASDAQ:SGEN)

76.28
BATS BZX Real-Time Price
As of 3:32pm ET
 -2.08 / -2.65%
Today’s Change
50.71
Today|||52-Week Range
84.37
+34.63%
Year-to-Date

Today’s Trading

Previous close78.36
Today’s open78.14
Day’s range76.28 - 78.80
Volume217,643
Average volume (3 months)928,502
Market cap$13.4B
Data as of 3:32pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)-60.51%
Earnings growth (this year)+6.32%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+35.76%
P/E ratioNM
Price/Sales13.64
Price/Book9.96

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.58-3.05%
IONSIonis Pharmaceutical...+0.17+0.25%
ALNYAlnylam Pharmaceutic...-0.65-0.79%
GLPGGalapagos NV-2.51-1.51%
Data as of 3:34pm ET, 08/23/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$654.7M
Annual profit (last year)-$222.7M
Net profit margin-34.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Financial &
Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts